My Face Lady Revenue and Competitors

Houston, TX USA

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • My Face Lady's estimated annual revenue is currently $8.6M per year.(i)
  • My Face Lady's estimated revenue per employee is $216,000

Employee Data

  • My Face Lady has 40 Employees.(i)
  • My Face Lady grew their employee count by 3% last year.

My Face Lady's People

NameTitleEmail/Phone
1
Nurse InjectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.1M27-4%N/AN/A
#2
$6.5M30-12%N/AN/A
#3
$271.4M869N/AN/AN/A
#4
$26.2M97-5%N/AN/A
#5
$7.3M343%N/AN/A
#6
$89.1M30049%N/AN/A
#7
$7.1M330%N/AN/A
#8
$170.4M505-3%N/AN/A
#9
$9.7M45-4%N/AN/A
#10
$42.5M1435%N/AN/A
Add Company

What Is My Face Lady?

For your comfort and safety, our experienced providers have been personally trained by one of the inventors named on the Botox® patent, Dr. Howard Katz. We offer treatments to correct problem areas such as frown lines, crows feet, smoker’s lines, and forehead lines with the use of Botox® and Dysport®. We also offer an array of services with hyaluronic fillers such as cheek enhancement and lip augmentation. We offer minimally invasive procedures in the comfort of your own home. We come to you!

keywords:N/A

N/A

Total Funding

40

Number of Employees

$8.6M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

My Face Lady News

2022-04-20 - Viola Davis Calls Online Criticism of Her ‘First Lady’ Performance a Hurtful “Occupational Hazard”

Davis said, though, that regardless of her performance choices or what those around her or online say, “ultimately, I feel like it is my job as...

2022-04-20 - Viola Davis responds to criticism of her Michelle Obama portrayal in The First Lady

... way she held her face while playing the former first lady. ... But ultimately I feel like it is my job as a leader to make bold choices.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.7M40-27%N/A
#2
$75M400%N/A
#3
$4.8M40-13%N/A
#4
$8M40-20%N/A
#5
$3.8M40-11%N/A